Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7444706 | 0.92 | ACE (0.63) | ACE | |
| SCHEMBL7315920 | 0.89 | ACE (0.56) | ACE | |
| SCHEMBL7324519 | 0.88 | ACE (0.61) | ACE | |
| SCHEMBL7317418 | 0.88 | ACE (0.69) | ACE | |
| SCHEMBL7325043 | 0.86 | ACE (0.64) | ACE | |
| SCHEMBL7317325 | 0.86 | ACE (0.64) | ACE | |
| SCHEMBL9809009 | 0.84 | FCER2 (0.53) | FCER2 | |
| SCHEMBL9808987 | 0.84 | FCER2 (0.53) | FCER2 | |
| SCHEMBL9809011 | 0.82 | FCER2 (0.51) | FCER2 | |
| SCHEMBL9809015 | 0.82 | FCER2 (0.51) | FCER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5262436-A | Administering; enzyme inhibitor | SCHERING CORPORATION (US) | 1993-11-16 | — | — | US | disclosed |
| EP-0566157-A1 | Neutral metalloendopeptidase inhibitors in the treatment of hypertension | SCHERING CORPORATION (US) | 1993-10-20 | — | — | EP | disclosed |
| US-5061710-A | Atrial natriuretic factors | SCHERING CORPORATION (US) | 1991-10-29 | — | — | US | disclosed |
| US-4929641-A | DIURETICS, ANGIOTENSIN CONVERTING ENZYMES | SCHERING CORPORATION (US) | 1990-05-29 | — | — | US | disclosed |
| US-4801609-A | Mercapto-acylamino acid antihypertensives | SCHERING CORPORATION (US) | 1989-01-31 | — | — | US | disclosed |
| EP-0254032-A2 | Neutral metalloendopeptidase inhibitors in the treatment of hypertension | SCHERING CORPORATION (US) | 1988-01-27 | — | — | EP | disclosed |